Notícias e Atividades da Jaguar Animal Health

Jaguar Animal Health é uma empresa listada sob o símbolo JAGX (US).

Jaguar Animal Health tem presença direta em 2 países.

Eles estão dentro:

• Saúde67%
• Farmacêutica33%

Veja o organograma con seus 24 executivos principais

Biografias mais buscadas da Jaguar Animal Health

• Lisa Conte, Chief Executive Officer, Executive Director
• John Micek, Director
• James Bochnowski, Chairman of the Board

Criar um alerta
para seguir os movimentos de executivos da Jaguar Animal Health.

Jaguar Animal Health possui 1.837 concorrentes concorrentes Pfizer (Estados Unidos), Johnson & Johnson (Estados Unidos) e Sanofi (França).

Popular M&A news in Farmacêutica

• Supernus Pharmaceuticals has announced the acquisition of Sage Therapeutics  (publicado em 16 de junho de 2025).
• Juvenescence acaba de anunciar uma arrecadação de fundos de 76 milhões de dólares. (publicado em 22 de maio de 2025).
• Kincell Bio acaba de anunciar uma arrecadação de fundos de 22 milhões de dólares. (publicado em 22 de maio de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Amanda Moore - Vice President, Program Leadership and Clinical Operations da Abeona Therapeutics
• Jean-Michel Demeure - Vice President, Finance Global Operations da Sanofi

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Jaguar Animal Health

• Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
• Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
• Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Jaguar Health, Inc.
• Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
• Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
• Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
• Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders | Jaguar Health, Inc.
• Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
• Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
• Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
• View more press releases Close

Redes sociais sobre Jaguar Animal Health

• Jaguar Animal Health na Wikipedia, Google News e Yahoo Finance
• Jaguar Animal Health na LinkedIn, Twitter e YouTube